Telomir Pharmaceuticals is a preclinical stage company focused on the science of lengthening telomere caps, which the company believes will extend human lifespans and improve quality of life as people age. Preclinical tests showed that the company's signature therapy, Telomir-1, appeared to correct a rare genetic condition that shortens life span, continuing a string of positive test announcements.
